Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
03:52:13 EDT Thu 02 May 2024
Enter Symbol
or Name
USA
CA



Q:EDAP - EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE - http://www.edaptechnomed.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
EDAP - Q0.14.90·7.230.77.10+0.060.927.21691407.18  7.27  6.9812.23  3.60May 01Apr 2315 min RT 2¢

Recent Trades - Last 10 of 140
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-23 08:00U:EDAPNews ReleaseEDAP Announces Final Results from HIFI Study Comparing Outcomes of Focal One(TM) HIFU Versus Radical Prostatectomy to be Presented During Plenary Session at the Upcoming 119th American Urological Association (AUA) Annual Meeting
2024-03-27 07:00U:EDAPNews ReleaseEDAP Reports Fourth Quarter and Full-Year 2023 Financial Results
2024-03-13 07:00U:EDAPNews ReleaseEDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024
2024-03-06 07:00U:EDAPNews ReleaseEDAP to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
2024-03-04 07:00U:EDAPNews ReleaseEDAP Announces FDA Breakthrough Device Designation for Focal One(TM) in the Treatment of Deep Infiltrating Rectal Endometriosis
2024-02-29 07:00U:EDAPNews ReleaseEDAP Announces Record Preliminary Fourth Quarter and Full-Year 2023 Revenues
2024-02-01 08:00U:EDAPNews ReleaseEDAP Announces Completion of Enrollment in Phase 3 Study Evaluating Focal One HIFU Therapy for the Treatment of Deep Infiltrating Rectal Endometriosis
2024-01-08 08:00U:EDAPNews ReleaseEDAP Announces Preliminary Fourth Quarter Record Focal One ‚ ® System Sales and Placements
2024-01-02 08:00U:EDAPNews ReleaseEDAP Appoints Ken Mobeck, Global Chief Financial Officer, and Francois Dietsch, Global Chief Accounting Officer
2023-12-12 08:00U:EDAPNews ReleaseEDAP Announces Positive Opinion for Reimbursement from the French National Authority for Health (HAS) for HIFU treatment of Prostate Cancer
2023-12-06 16:30U:EDAPNews ReleaseEDAP Appoints Lance Willsey, M.S., M.D. to Board of Directors
2023-11-30 08:00U:EDAPNews ReleaseEDAP Receives 2023 Industry Category Award from the French National Institute for Intellectual Property (INPI) for Its Therapeutic Ultrasound Technology
2023-11-20 08:00U:EDAPNews ReleaseEDAP to Present at Piper Sandler ¢ € ™s 35th Annual Healthcare Conference
2023-11-09 06:00U:EDAPNews ReleaseEDAP Announces Third Quarter 2023 Financial Results
2023-11-06 08:00U:EDAPNews ReleaseEDAP to Present at the Jefferies London Healthcare Conference
2023-10-26 08:00U:EDAPNews ReleaseEDAP TMS SA to Announce Third Quarter 2023 Financial Results on November 9, 2023
2023-09-06 08:00U:EDAPNews ReleaseEDAP to Present at Morgan Stanley Annual Global Healthcare Conference and the H.C. Wainwright Annual Global Investment Conference
2023-08-24 06:30U:EDAPNews ReleaseEDAP Announces Second Quarter 2023 Financial Results
2023-08-10 08:00U:EDAPNews ReleaseEDAP TMS SA to Announce Second Quarter 2023 Financial Results on August 24, 2023 ‚   ‚  
2023-07-26 08:00U:EDAPNews ReleaseEDAP Announces Reimbursement Approval in Switzerland for the Use of High-Intensity Focused Ultrasound (HIFU) in the Treatment of Prostate Cancer